Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
Darius P. Zlotos, Ralf Jockers, Erika Cecon, et al.
Journal of Medicinal Chemistry (2013) Vol. 57, Iss. 8, pp. 3161-3185
Closed Access | Times Cited: 151

Showing 26-50 of 151 citing articles:

<p>Role of Melatonin in the Regulation of Pain</p>
Shanshan Xie, Wenguo Fan, Hongwen He, et al.
Journal of Pain Research (2020) Vol. Volume 13, pp. 331-343
Open Access | Times Cited: 54
The melatonin receptor 1B gene links circadian rhythms and type 2 diabetes mellitus: an evolutionary story
Hui Zhu, Zhijia Zhao, Hongyi Liu, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1262-1286
Open Access | Times Cited: 18
Design and validation of the first cell‐impermeant melatonin receptor agonist
Florence Gbahou, Erika Cecon, Guillaume Viault, et al.
British Journal of Pharmacology (2017) Vol. 174, Iss. 14, pp. 2409-2421
Open Access | Times Cited: 59
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014)
Silvia Rivara, Daniele Pala, Annalida Bedini, et al.
Expert Opinion on Therapeutic Patents (2015) Vol. 25, Iss. 4, pp. 425-441
Open Access | Times Cited: 54
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
Gilberto Spadoni, Annalida Bedini, Simone Lucarini, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 18, pp. 7512-7525
Open Access | Times Cited: 52
Melatonergic drugs in development
Alessia Carocci, Alessia Catalano, Maria Stefania Sinicropi
Clinical Pharmacology Advances and Applications (2014), pp. 127-127
Open Access | Times Cited: 52
Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function
Atsuro Oishi, Erika Cecon, Ralf Jockers
International review of cell and molecular biology (2018), pp. 59-77
Closed Access | Times Cited: 50
Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives
Stefano Comai, Martha López-Canul, Danilo De Gregorio, et al.
Pharmacological Research (2019) Vol. 144, pp. 343-356
Closed Access | Times Cited: 50
Structural insights into melatonin receptors
Benjamin Stauch, Linda C. Johansson, Vadim Cherezov
FEBS Journal (2019) Vol. 287, Iss. 8, pp. 1496-1510
Open Access | Times Cited: 50
Melatonin receptor structures shed new light on melatonin research
Erika Cecon, Lei Liu, Ralf Jockers
Journal of Pineal Research (2019) Vol. 67, Iss. 4
Closed Access | Times Cited: 49
Indole-based melatonin analogues: Synthetic approaches and biological activity
Suyan Wang, Xin‐Chi Shi, Pedro Laborda
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111847-111847
Closed Access | Times Cited: 45
The roles of melatonin and potassium channels in relaxation response to ang 1–7 in diabetic rat isolated aorta
Nazar M. Shareef Mahmood, Atif Mahmood, Ismail M. Maulood
Cytotechnology (2025) Vol. 77, Iss. 2
Closed Access
Recent advances in melatonin regulation of drought tolerance in plants
Mingzhao Luo, Dandan Zhang, Wensi Tang, et al.
Tropical Plants (2025) Vol. 4, Iss. 1
Closed Access
Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway
Erika Cecon, Min Chen, Marina Marçola, et al.
The FASEB Journal (2015) Vol. 29, Iss. 6, pp. 2566-2582
Closed Access | Times Cited: 49
Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus
Paul Pévet
Expert Opinion on Therapeutic Targets (2016) Vol. 20, Iss. 10, pp. 1209-1218
Closed Access | Times Cited: 44
Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
Ovidiu Constantin Baltatu, Sergio Senar, Luciana Aparecida Campos, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4342-4342
Open Access | Times Cited: 41
Melatonin mediates vasodilation through both direct and indirect activation of BKCa channels
Tiantian Zhao, Hanmeng Zhang, Chun‐Sil Jin, et al.
Journal of Molecular Endocrinology (2017) Vol. 59, Iss. 3, pp. 219-233
Open Access | Times Cited: 40
Structure-based discovery of potent and selective melatonin receptor agonists
Nilkanth Patel, Xi‐Ping Huang, Jessica M. Grandner, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 35
Melatonin and the circadian system: Keys for health with a focus on sleep
Paul Pévet, Étienne Challet, Marie‐Paule Felder‐Schmittbuhl
Handbook of clinical neurology (2021), pp. 331-343
Closed Access | Times Cited: 28
Sleep, Melatonin, and the Menopausal Transition: What Are the Links?
Shazia Jehan, Girardin Jean–Louis, Ferdinand Zizi, et al.
Sleep Science (2017) Vol. 10, Iss. 01, pp. 11-18
Open Access | Times Cited: 39
The potential influence of LED lighting on mental illness
Michael Bauer, Tasha Glenn, Scott Monteith, et al.
The World Journal of Biological Psychiatry (2017) Vol. 19, Iss. 1, pp. 59-73
Closed Access | Times Cited: 39
Novel N-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential
Mario de la Fuente Revenga, Nerea Fernández‐Sáez, Clara Herrera‐Arozamena, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 12, pp. 4998-5014
Closed Access | Times Cited: 38
Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases
Clara Herrera‐Arozamena, Olaia Martí‐Marí, Martín Estrada, et al.
Molecules (2016) Vol. 21, Iss. 9, pp. 1165-1165
Open Access | Times Cited: 36
Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptors
Céline Legros, Clémence Dupré, Chantal Brasseur, et al.
Pharmacology Research & Perspectives (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 30
Design and Discovery of Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists
Jianjun Cheng, John D. McCorvy, Patrick M. Giguère, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 21, pp. 9866-9880
Closed Access | Times Cited: 31

Scroll to top